Abstract
The ideal therapeutic strategy would be to reverse the underlying cause of cardiac dysfunction, such as hypertension or valvular disease, while removing or minimizing those concurrent conditions or factors that tend to exacerbate symptoms. For most patients, vasodilator therapy has been shown to reduce mortality in moderate to advanced CHF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have